KeyCorp Upgrades LifeStance Health Group (NASDAQ:LFST) to Strong-Buy

KeyCorp upgraded shares of LifeStance Health Group (NASDAQ:LFST) to a strong-buy rating in a report published on Monday morning,Zacks.com reports.

Several other research analysts also recently issued reports on the stock. William Blair restated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. Finally, Canaccord Genuity Group began coverage on LifeStance Health Group in a report on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price target for the company. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $8.58.

LifeStance Health Group Stock Up 5.8 %

LFST opened at $6.91 on Monday. LifeStance Health Group has a 1-year low of $4.64 and a 1-year high of $8.61. The business has a 50 day moving average of $7.33 and a 200-day moving average of $7.33. The stock has a market capitalization of $2.66 billion, a price-to-earnings ratio of -26.58 and a beta of 1.30. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

Insider Buying and Selling

In related news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the transaction, the insider now owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

A number of large investors have recently bought and sold shares of LFST. Blue Trust Inc. boosted its stake in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after purchasing an additional 2,122 shares in the last quarter. R Squared Ltd acquired a new position in LifeStance Health Group in the fourth quarter valued at about $80,000. Ameriprise Financial Inc. bought a new stake in LifeStance Health Group during the fourth quarter worth about $87,000. Cibc World Markets Corp acquired a new stake in shares of LifeStance Health Group during the fourth quarter worth approximately $96,000. Finally, Forum Financial Management LP bought a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $110,000. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.